$AMMJ
American Cannabis Company, Inc. Stock $ammj

$ammj Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-K Financial Statement

#000190359623000316 Filed on April 17, 2023

Income Statement

Concept	2023 Q2	2022 Q4	2022
Revenue	$852.7K	$11.32M	$18.81M
YoY Change	-82.03%	1458.72%	675.55%
Cost Of Revenue	$486.3K	$9.851M	$16.27M
YoY Change	-88.15%	2138.5%	1088.5%
Gross Profit	$366.4K	$1.470M	$2.537M
YoY Change	-42.81%	413.54%	140.23%
Gross Profit Margin	42.97%	12.98%	13.49%
Selling, General & Admin	$490.8K	$904.8K	$3.059M
YoY Change	-37.86%	23.7%	30.35%
% of Gross Profit	133.97%	61.56%	120.57%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$60.18K	$114.2K	$227.5K
YoY Change	71.75%	543.21%	138.1%
% of Gross Profit	16.43%	7.77%	8.97%
Operating Expenses	$498.8K	$904.8K	$3.143M
YoY Change	-39.48%	23.7%	33.92%
Operating Profit	-$132.4K	$565.0K	-$605.7K
YoY Change	-27.84%	-226.89%	-53.08%
Interest Expense	-$32.73K	-$110.1K	$78.09K
YoY Change	-279.51%	285.81%	-203.6%
% of Operating Profit		-19.49%
Other Income/Expense, Net	$144.2K	$2.530K	-$27.54K
YoY Change	1037.7%	-92.22%	-176.74%
Pretax Income	$11.84K	$457.4K	-$633.2K
YoY Change	-106.93%	-157.87%	-56.01%
Income Tax		$0.00
% Of Pretax Income		0.0%
Net Earnings	$11.84K	$457.4K	-$633.2K
YoY Change	-106.93%	-157.87%	-56.01%
Net Earnings / Revenue	1.39%	4.04%	-3.37%
Basic Earnings Per Share	$0.00
Diluted Earnings Per Share	$0.00	$0.01	-$0.01
COMMON SHARES
Basic Shares Outstanding	92.15M shares	85.73M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2023 Q2	2022 Q4	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$102.3K	$127.1K	$127.1K
YoY Change	-88.33%	-81.12%	-81.12%
Cash & Equivalents	$92.74K	$117.5K	$117.6K
Short-Term Investments	$9.600K	$9.600K	$9.600K
Other Short-Term Assets	$77.95K	$73.93K	$73.93K
YoY Change	-26.5%	43.97%	43.97%
Inventory	$508.3K	$353.0K	$353.0K
Prepaid Expenses
Receivables	$293.3K	$469.1K	$469.1K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$981.9K	$1.023M	$1.023M
YoY Change	-33.14%	0.84%	0.84%
LONG-TERM ASSETS
Property, Plant & Equipment	$438.0K	$427.7K	$1.032M
YoY Change	24.69%	13.79%	118.79%
Goodwill	$1.332M	$1.332M
YoY Change	-32.89%	-32.89%
Intangibles	$1.131M	$1.332M
YoY Change	59.47%	78.58%
Long-Term Investments
YoY Change
Other Assets	$6.000K	$6.000K	$6.000K
YoY Change	-84.35%	0.0%	0.0%
Total Long-Term Assets	$3.470M	$3.593M	$3.593M
YoY Change	3.87%	11.98%	11.98%
TOTAL ASSETS
Total Short-Term Assets	$981.9K	$1.023M	$1.023M
Total Long-Term Assets	$3.470M	$3.593M	$3.593M
Total Assets	$4.452M	$4.616M	$4.616M
YoY Change	-7.43%	9.31%	9.31%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$809.3K	$679.2K	$847.4K
YoY Change	58.79%	179.86%	249.19%
Accrued Expenses	$91.43K	$39.13K	$246.8K
YoY Change	863.14%	-47.22%	30.64%
Deferred Revenue
YoY Change
Short-Term Debt	$550.0K	$550.0K	$550.0K
YoY Change	0.0%	-50.0%	-50.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$2.168M	$2.099M	$2.099M
YoY Change	-29.14%	8.81%	8.81%
LONG-TERM LIABILITIES
Long-Term Debt	$335.7K	$150.0K	$150.0K
YoY Change
Other Long-Term Liabilities	$454.6K	$497.4K	$497.4K
YoY Change	384.86%	184.21%	184.21%
Total Long-Term Liabilities	$790.2K	$613.0K	$647.4K
YoY Change	742.9%	250.26%	269.92%
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.168M	$2.099M	$2.099M
Total Long-Term Liabilities	$790.2K	$613.0K	$647.4K
Total Liabilities	$2.959M	$2.747M	$2.747M
YoY Change	-6.2%	30.53%	30.53%
SHAREHOLDERS EQUITY
Retained Earnings	-$10.53M	-$10.08M
YoY Change	3.86%	6.7%
Common Stock	$922.00	$922.00
YoY Change	7.58%	12.58%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$1.493M	$1.870M	$1.870M
YoY Change
Total Liabilities & Shareholders Equity	$4.452M	$4.616M	$4.616M
YoY Change	-7.43%	9.31%	9.31%

Cashflow Statement

Concept	2023 Q2	2022 Q4	2022
OPERATING ACTIVITIES
Net Income	$11.84K	$457.4K	-$633.2K
YoY Change	-106.93%	-157.87%	-56.01%
Depreciation, Depletion And Amortization	$60.18K	$114.2K	$227.5K
YoY Change	71.75%	543.21%	138.1%
Cash From Operating Activities	$37.21K	-$267.7K	-$199.0K
YoY Change	-101.28%	-13.13%	-79.23%
INVESTING ACTIVITIES
Capital Expenditures	$10.00	-$11.64K	$103.7K
YoY Change	-100.36%	-67.67%	-107.07%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$10.00	$11.64K	-$103.7K
YoY Change	-99.64%	-132.33%	-92.93%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-950.0	182.1K	-$250.2K
YoY Change	-99.82%	39.49%	-118.25%
NET CHANGE
Cash From Operating Activities	37.21K	-267.7K	-$199.0K
Cash From Investing Activities	-10.00	11.64K	-$103.7K
Cash From Financing Activities	-950.0	182.1K	-$250.2K
Net Change In Cash	36.25K	-73.97K	-$552.9K
YoY Change	-101.05%	-65.37%	-47.48%
FREE CASH FLOW
Cash From Operating Activities	$37.21K	-$267.7K	-$199.0K
Capital Expenditures	$10.00	-$11.64K	$103.7K
Free Cash Flow	$37.20K	-$256.1K	-$302.6K
YoY Change	-101.28%	-5.91%	-159.58%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0000945617
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent		usd
CY2021Q4	us-gaap	Notes Payable To Bank Noncurrent NotesPayableToBankNoncurrent		usd
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2022	ammj	Llitigation Settlement Expense LlitigationSettlementExpense		usd
CY2022	ammj	Debt Forgiveness DebtForgiveness		usd
CY2022	us-gaap	Litigation Settlement Expense LitigationSettlementExpense		usd
CY2022	ammj	Debt Instrument Decrease Forgivenes DebtInstrumentDecreaseForgivenes		usd
CY2021	ammj	Litigation Payable LitigationPayable		usd
CY2022	ammj	Payment For Acquisition Of Assets PaymentForAcquisitionOfAssets		usd
CY2022	ammj	Payments To Acquire Intangible Asset PaymentsToAcquireIntangibleAsset		usd
CY2022	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable		usd
CY2021	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable		usd
CY2021	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable		usd
CY2022	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
CY2021	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
CY2022	us-gaap	Interest Paid InterestPaid		usd
CY2021	us-gaap	Interest Paid InterestPaid		usd
CY2021	ammj	Stock Based Compensation Third Party StockBasedCompensationThirdParty		usd
CY2022	ammj	Stock Issued For Receivables StockIssuedForReceivables		usd
CY2022	ammj	Stock Issued For Acquisition StockIssuedForAcquisition		usd
CY2021	ammj	Stock Issued For Cashless Exercise Of Warrants StockIssuedForCashlessExerciseOfWarrants		usd
CY2022Q4	us-gaap	Cash Cash		usd
CY2022Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Accounts Payable BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable		usd
CY2021Q4	ammj	Stock Payable Amounts StockPayableAmounts		usd
CY2022Q4	ammj	Less Amount Representing Interest LessAmountRepresentingInterest		usd
CY2022Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding		usd
CY2021Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding		usd
CY2022Q4	us-gaap	Convertible Notes Payable ConvertibleNotesPayable		usd
CY2022Q4	ammj	Dilutive Securities Amount DilutiveSecuritiesAmount		usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit		usd
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit		usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements		usd
CY2022Q4	us-gaap	Deferred Tax Asset Interest Carryforward DeferredTaxAssetInterestCarryforward		usd
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet		usd
CY2021Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet		usd
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	000-26108
CY2022	dei	Entity Registrant Name EntityRegistrantName	AMERICAN CANNABIS COMPANY, INC
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	90-1116625
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	200 Union Street, Ste.
CY2022	dei	Entity Address Address Line2 EntityAddressAddressLine2	200
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	Lakewood
CY2022	dei	Entity Address State Or Province EntityAddressStateOrProvince	CO
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	80228
CY2022	dei	City Area Code CityAreaCode	303
CY2022	dei	Local Phone Number LocalPhoneNumber	974-4770
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	true
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2022Q4	dei	Entity Public Float EntityPublicFloat	5076892	usd
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	92152938	shares
CY2022	dei	Auditor Name AuditorName	Macias Gini & O’Connell LLP
CY2022	dei	Auditor Firm AuditorFirmId	324
CY2022	dei	Auditor Location AuditorLocation	Irvine, CA
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	117547	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	670423	usd
CY2022Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	469111	usd
CY2021Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	11316	usd
CY2022Q4	ammj	Deposit Assets Current DepositAssetsCurrent	9595	usd
CY2021Q4	ammj	Deposit Assets Current DepositAssetsCurrent	2895	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	352971	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	278608	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	73933	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	51353	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	1023157	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	1014595	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	427669	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	375832	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1223242	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	745937	usd
CY2022Q4	us-gaap	Goodwill Goodwill	1332113	usd
CY2021Q4	us-gaap	Goodwill Goodwill	1985113	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	604020	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	95722	usd
CY2022Q4	us-gaap	Deposit Assets DepositAssets	6000	usd
CY2021Q4	us-gaap	Deposit Assets DepositAssets	6000	usd
CY2022Q4	us-gaap	Other Assets OtherAssets	3165375	usd
CY2021Q4	us-gaap	Other Assets OtherAssets	2832772	usd
CY2022Q4	us-gaap	Assets Assets	4616201	usd
CY2021Q4	us-gaap	Assets Assets	4223199	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	679163	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	242679	usd
CY2022Q4	ammj	Advance From Client AdvanceFromClient	280705	usd
CY2021Q4	ammj	Advance From Client AdvanceFromClient	111892	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	233348	usd
CY2021Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	161718	usd
CY2022Q4	ammj	Stock Payable StockPayable	74343	usd
CY2021Q4	ammj	Stock Payable StockPayable	42207	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	181661	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	95722	usd
CY2022Q4	ammj	Litigation Settlement Current LitigationSettlementCurrent	100000	usd
CY2021Q4	ammj	Litigation Settlement Current LitigationSettlementCurrent	175000	usd
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	550000	usd
CY2021Q4	us-gaap	Notes Payable Current NotesPayableCurrent	1100000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2099220	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1929218	usd
CY2022Q4	ammj	Litigation Settlement LitigationSettlement	75000	usd
CY2021Q4	ammj	Litigation Settlement LitigationSettlement	175000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	422359	usd
CY2022Q4	us-gaap	Notes Payable To Bank Noncurrent NotesPayableToBankNoncurrent	150000	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	612960	usd
CY2021Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	175000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	2746579	usd
CY2021Q4	us-gaap	Liabilities Liabilities	2104218	usd
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	92152938	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	81902938	shares
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	922	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	819	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	11949409	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	11565679	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-10080709	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-9447517	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	1869622	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	2118981	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	4616201	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	4223199	usd
CY2022	ammj	Consulting And Advisory Revenues ConsultingAndAdvisoryRevenues	475837	usd
CY2021	ammj	Consulting And Advisory Revenues ConsultingAndAdvisoryRevenues	381094	usd
CY2022	ammj	Equipment Supplies Revenues EquipmentSuppliesRevenues	17539377	usd
CY2021	ammj	Equipment Supplies Revenues EquipmentSuppliesRevenues	1037962	usd
CY2022	ammj	Cannabis Products CannabisProducts	793331	usd
CY2021	ammj	Cannabis Products CannabisProducts	1006148	usd
CY2022	us-gaap	Revenues Revenues	18808545	usd
CY2021	us-gaap	Revenues Revenues	2425204	usd
CY2022	ammj	Cost Of Consulting And Advisory CostOfConsultingAndAdvisory	61246	usd
CY2021	ammj	Cost Of Consulting And Advisory CostOfConsultingAndAdvisory	36179	usd
CY2022	ammj	Cost Of Equipment Supplies CostOfEquipmentSupplies	15230648	usd
CY2021	ammj	Cost Of Equipment Supplies CostOfEquipmentSupplies	758940	usd
CY2022	ammj	Cost Of Cannabis Product CostOfCannabisProduct	979437	usd
CY2021	ammj	Cost Of Cannabis Product CostOfCannabisProduct	573937	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	16271331	usd
CY2021	us-gaap	Cost Of Revenue CostOfRevenue	1369056	usd
CY2022	us-gaap	Gross Profit GrossProfit	2537214	usd
CY2021	us-gaap	Gross Profit GrossProfit	1056148	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2833140	usd
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2050272	usd
CY2022	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	225950	usd
CY2021	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	199968	usd
CY2022	ammj	Bad Debt Expense BadDebtExpense	5438	usd
CY2021	ammj	Bad Debt Expense BadDebtExpense	54435	usd
CY2021	ammj	Llitigation Settlement Expense LlitigationSettlementExpense	350000	usd
CY2022	ammj	Stock Based Compensation Expense StockBasedCompensationExpense	78342	usd
CY2021	ammj	Stock Based Compensation Expense StockBasedCompensationExpense	42206	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	3142870	usd
CY2021	us-gaap	Operating Expenses OperatingExpenses	2696881	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-605656	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-1640733	usd
CY2022	us-gaap	Interest Expense InterestExpense	78086	usd
CY2021	us-gaap	Interest Expense InterestExpense	75374	usd
CY2021	ammj	Debt Forgiveness DebtForgiveness	-240975	usd
CY2022	us-gaap	Other Income OtherIncome	50550	usd
CY2021	us-gaap	Other Income OtherIncome	35883	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-27536	usd
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	201484	usd
CY2022	ammj	Net Income Loss1 NetIncomeLoss1	-633192	usd
CY2021	ammj	Net Income Loss1 NetIncomeLoss1	-1439249	usd
CY2022	ammj	Net Loss NetLoss	-633192	usd
CY2021	ammj	Net Loss NetLoss	-1439249	usd
CY2022	ammj	Basic Net Loss Per Common Share BasicNetLossPerCommonShare	-0.01
CY2021	ammj	Basic Net Loss Per Common Share BasicNetLossPerCommonShare	-0.02
CY2022	ammj	Basic And Diluted Weighted Average Common Shares Outstanding BasicAndDilutedWeightedAverageCommonSharesOutstanding	85727938	shares
CY2021	ammj	Basic And Diluted Weighted Average Common Shares Outstanding BasicAndDilutedWeightedAverageCommonSharesOutstanding	78387733	shares
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-633192	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-1439249	usd
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	64344	usd
CY2021	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	54345	usd
CY2022	ammj	Depreciation Expense DepreciationExpense	227533	usd
CY2021	ammj	Depreciation Expense DepreciationExpense	95562	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	266207	usd
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	42207	usd
CY2021	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	350000	usd
CY2022	ammj	Operating Lease Expense1 OperatingLeaseExpense1	192432	usd
CY2021	ammj	Operating Lease Expense1 OperatingLeaseExpense1	-95722	usd
CY2021	ammj	Debt Instrument Decrease Forgivenes DebtInstrumentDecreaseForgivenes	240975	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	522139	usd
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	40795	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	74363	usd
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	144034	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	29282	usd
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1051	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	436484	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	229524	usd
CY2022	ammj	Advances From Clients AdvancesFromClients	-168813	usd
CY2021	ammj	Advances From Clients AdvancesFromClients	-23409	usd
CY2022	ammj	Litigation Payable LitigationPayable	-175000	usd
CY2022	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	71630	usd
CY2021	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	113349	usd
CY2022	us-gaap	Increase Decrease In Operating Liabilities IncreaseDecreaseInOperatingLiabilities	-192432	usd
CY2021	us-gaap	Increase Decrease In Operating Liabilities IncreaseDecreaseInOperatingLiabilities	95722	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-198965	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-957978	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	103675	usd
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	357801	usd
CY2021	ammj	Payment For Acquisition Of Assets PaymentForAcquisitionOfAssets	1100000	usd
CY2021	ammj	Payments To Acquire Intangible Asset PaymentsToAcquireIntangibleAsset	8159	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-103675	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1465960	usd
CY2021	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	130186	usd
CY2022	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	550000	usd
CY2022	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	150000	usd
CY2022	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	149764	usd
CY2021	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	1241043	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-250236	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1371229	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-552875	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1052709	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	670423	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1723132	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	117547	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	670423	usd
CY2022	ammj	Stock Based Compensation Third Party StockBasedCompensationThirdParty	700730	usd
CY2021	ammj	Stock Issued For Receivables StockIssuedForReceivables	690000	usd
CY2021	ammj	Stock Issued For Acquisition StockIssuedForAcquisition	1100000	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	1627187	usd
CY2021	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	690000	usd
CY2021	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	1241043	usd
CY2021	us-gaap	Profit Loss ProfitLoss	-1439249	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	2118981	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	2118981	usd
CY2022	us-gaap	Stock Issued During Period Value Employee Benefit Plan StockIssuedDuringPeriodValueEmployeeBenefitPlan	46226	usd
CY2022	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	169979	usd
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	117628	usd
CY2022	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	50000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-633192	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	1869622	usd
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_841_eus-gaap--UseOfEstimates_zT6JjXMyCZr9" style="margin: 0"><span id="xdx_868_z5b1rqJk6C13" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Use of Estimates in Financial Reporting</i></span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the amount of assets and liabilities, and disclosures of contingent assets and liabilities, as of the date of the consolidated financial statements during the periods presented. Actual results could differ from these estimates. Estimates and assumptions are reviewed periodically, and the effects of revisions are reflected in the consolidated financial statements in the period in which they are deemed to be necessary. Significant estimates made in the accompanying consolidated financial statements include but are not limited to following those related to revenue recognition, allowance for doubtful accounts and unbilled services, lives and recoverability of equipment and other long-lived assets, the allocation of the asset purchase price, contingencies, and litigation. The Company is subject to uncertainties, such as the impact of future events, economic, environmental, and political factors, and changes in the business climate; therefore, actual results may differ from those estimates. When no estimate in a given range is deemed to be better than any other when estimating contingent liabilities, the low end of the range is accrued. Accordingly, the accounting estimates used in preparing the Company's consolidated financial statements will change as new events occur, as more experience is acquired, as additional information is obtained and as the Company's operating environment changes. Changes in estimates are made when circumstances warrant. Such changes and refinements in estimation methodologies are reflected in reported results of operations; if material, the effects of changes in estimates are disclosed in the notes to the consolidated financial statements.</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p>
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	4071	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	82540	usd
CY2022	ammj	Bad Debt Expense BadDebtExpense	5438	usd
CY2021	ammj	Bad Debt Expense BadDebtExpense	54435	usd
CY2021	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	42206	usd
CY2022	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_845_eus-gaap--ConcentrationRiskCreditRisk_z4N43YQGO6Kb" style="margin: 0"><span id="xdx_86A_zJe1yzjo3uTe" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Significant Clients and Customers</i></span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the year ended December 31, 2022, eight customers accounted for 87.33% of the Company's total revenues from its consulting, soil, and products revenue lines for the period. At December 31, 2021, nine customers accounted for 50.1% of the Company’s total revenues from its consulting and soil and product revenue lines for the period.</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At December 31, 2022, three customers accounted for 84.76% of accounts receivable, net, consisting of customers for our products, soil, and consulting services product streams. At December 31, 2021, two customers accounted for 77.3% of accounts receivable, net, consisting of customers of our consulting services and soil, and products revenue streams.</span></p> <p style="margin: 0"/> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p>
CY2021Q4	us-gaap	Accounts Receivable Gross AccountsReceivableGross	93856	usd
CY2022	us-gaap	Amortization Of Acquisition Costs AmortizationOfAcquisitionCosts	186000	usd
CY2021	us-gaap	Revenue Recognition Sales Returns Reserve For Sales Returns RevenueRecognitionSalesReturnsReserveForSalesReturns	0	usd
CY2022	us-gaap	Advertising Expense AdvertisingExpense	266578	usd
CY2021	us-gaap	Advertising Expense AdvertisingExpense	116122	usd
CY2022	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	78342	usd
CY2022Q4	us-gaap	Asset Acquisition Contingent Consideration Liability AssetAcquisitionContingentConsiderationLiability	2912000	usd
CY2022Q4	us-gaap	Accounts Receivable Gross AccountsReceivableGross	469111	usd
CY2022	us-gaap	Legal Fees LegalFees	83095	usd
CY2022Q4	us-gaap	Inventory Gross InventoryGross	72172	usd
CY2022Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Property Plant And Equipment BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment	26715	usd
CY2022Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Other Noncurrent Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets	6000	usd
CY2022Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Intangibles BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles	800000	usd
CY2022Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Intangible Assets Other Than Goodwill BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill	1985113	usd
CY2022Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired Goodwill And Liabilities Assumed Less Noncontrolling Interest BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest	2890000	usd
CY2021	us-gaap	Adjustment For Amortization AdjustmentForAmortization	62223	usd
CY2022Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets	15000	usd
CY2022Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Inventory BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory	72172	usd
CY2022Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Equipment BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipment	26715	usd
CY2022Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Noncurrent Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets	6000	usd
CY2022Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Indefinite Lived Intangible Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets	119887	usd
CY2022Q4	us-gaap	Finite Lived Trademarks Gross FiniteLivedTrademarksGross	660000	usd
CY2022Q4	us-gaap	Finite Lived License Agreements Gross FiniteLivedLicenseAgreementsGross	810000	usd
CY2022Q4	ammj	Finite Lived Intangible Assets Gross Asset FiniteLivedIntangibleAssetsGrossAsset	1470000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1332113	usd
CY2021Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	136266	usd
CY2022Q4	ammj	Finished Goods Soil FinishedGoodsSoil	66557	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	4071	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	82540	usd
CY2022Q4	us-gaap	Accounts And Notes Receivable Net AccountsAndNotesReceivableNet	465040	usd
CY2021Q4	us-gaap	Accounts And Notes Receivable Net AccountsAndNotesReceivableNet	11316	usd
CY2022	ammj	Allowances For Badebt Expense AllowancesForBadebtExpense	5438	usd
CY2021	ammj	Allowances For Badebt Expense AllowancesForBadebtExpense	54435	usd
CY2021Q4	us-gaap	Restructuring Reserve Current RestructuringReserveCurrent	88843	usd
CY2021Q4	us-gaap	Deposit Liability Current DepositLiabilityCurrent	404143	usd
CY2021Q4	ammj	Deposits Recognized As Revenue DepositsRecognizedAsRevenue	381094	usd
CY2021Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	111892	usd
CY2022Q4	us-gaap	Restructuring Reserve Current RestructuringReserveCurrent	111892	usd
CY2022Q4	us-gaap	Deposit Liability Current DepositLiabilityCurrent	691769	usd
CY2022Q4	ammj	Deposits Recognized As Revenue DepositsRecognizedAsRevenue	522663	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	280705	usd
CY2022Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	38464	usd
CY2021Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	60900	usd
CY2022Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	206306	usd
CY2021Q4	ammj	Finished Goods Soil FinishedGoodsSoil	58594	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	41644	usd
CY2021Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	22848	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	352971	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	278608	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	427432	usd
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	431851	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	113650	usd
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	56019	usd
CY2022Q4	ammj	Property Plant And Equipment Net1 PropertyPlantAndEquipmentNet1	313782	usd
CY2021Q4	ammj	Property Plant And Equipment Net1 PropertyPlantAndEquipmentNet1	375832	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	1488464	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	255222	usd
CY2022Q4	ammj	Finite Lived Intangible Assets Net1 FiniteLivedIntangibleAssetsNet1	1223242	usd
CY2022	us-gaap	Acquired Finite Lived Intangible Assets Weighted Average Useful Life AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife	P11Y5M19D
CY2022	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	186000	usd
CY2021	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	62223	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	186000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	186000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	186000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	145997	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	54000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	463781	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	39130	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	74137	usd
CY2022Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	22029	usd
CY2021Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	18428	usd
CY2022Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	3931	usd
CY2021Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	592	usd
CY2022Q4	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	168258	usd
CY2021Q4	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	68559	usd
CY2022Q4	us-gaap	Accounts Payable And Other Accrued Liabilities AccountsPayableAndOtherAccruedLiabilities	233348	usd
CY2021Q4	us-gaap	Accounts Payable And Other Accrued Liabilities AccountsPayableAndOtherAccruedLiabilities	161716	usd
CY2022	ammj	Additional Expensed Incurred Amount AdditionalExpensedIncurredAmount	74342	usd
CY2022Q4	ammj	Stock Payable Amounts StockPayableAmounts	74342	usd
CY2022Q4	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	604020	usd
CY2022Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	604020	usd
CY2022Q4	ammj	Present Value Of Future Minimum Lease Payments PresentValueOfFutureMinimumLeasePayments	604020	usd
CY2022Q4	ammj	Current Obligations Under Leases CurrentObligationsUnderLeases	-181661	usd
CY2022Q4	us-gaap	Capital Lease Obligations CapitalLeaseObligations	422359	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	604020	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	604020	usd
CY2021Q4	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	275000	usd
CY2021Q4	ammj	Dilutive Securities Amount DilutiveSecuritiesAmount	275000	usd
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	428083	usd
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-623358	usd
CY2022	ammj	Nondeductible Expenses Including Nondeductible Premerger Losses NondeductibleExpensesIncludingNondeductiblePremergerLosses	-187711	usd
CY2021	ammj	Nondeductible Expenses Including Nondeductible Premerger Losses NondeductibleExpensesIncludingNondeductiblePremergerLosses	-163495	usd
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-615794	usd
CY2021	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	459863	usd
CY2021Q4	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	24457	usd
CY2022Q4	us-gaap	Deferred Tax Assets Other Tax Carryforwards DeferredTaxAssetsOtherTaxCarryforwards	1152244	usd
CY2021Q4	us-gaap	Deferred Tax Assets Other Tax Carryforwards DeferredTaxAssetsOtherTaxCarryforwards	1230904	usd
CY2021Q4	us-gaap	Deferred Tax Asset Interest Carryforward DeferredTaxAssetInterestCarryforward	24457	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Premiums And Other Receivables AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables	1040	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Premiums And Other Receivables AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables	17735	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	1153284	usd
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	1248639	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	1153284	usd
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	1248639	usd

Files In Submission

Name	View Source	Status
0001903596-23-000316-index-headers.html	Edgar Link	pending
0001903596-23-000316-index.html	Edgar Link	pending
0001903596-23-000316.txt	Edgar Link	pending
0001903596-23-000316-xbrl.zip	Edgar Link	pending
acc_10k.htm	Edgar Link	pending
ammj-20221231.xsd	Edgar Link	pending
ex31_1.htm	Edgar Link	pending
ex31_2.htm	Edgar Link	pending
ex32_1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image_001.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
ammj-20221231_def.xml	Edgar Link	unprocessable
ammj-20221231_lab.xml	Edgar Link	unprocessable
ammj-20221231_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
acc_10k_htm.xml	Edgar Link	completed
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
ammj-20221231_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AMMJ
American Cannabis Company, Inc. Stock $ammj

2023 Q2 Form 10-K Financial Statement

#000190359623000316 Filed on April 17, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AMMJ American Cannabis Company, Inc. Stock $ammj

2023 Q2 Form 10-K Financial Statement

#000190359623000316 Filed on April 17, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AMMJ
American Cannabis Company, Inc. Stock $ammj